Article
An advisory board to the Food and Drug Administration was unanimous in recommending the approval of Raptiva, a psoriasis drug manufactured by Genentech.
Psychosocial Impact of Alopecia Areata on Pediatric and Adolescent Patients
The Cutaneous Connection: Combatting Treatment Skepticism in Advanced Pediatric Atopic Dermatitis
Research Observe, Classify Adverse Event Profiles for Pediatric Patients Treated With JAK Inhibitors
The Cutaneous Connection: Episode 28- The Path to Understanding Pediatric Melanoma
Case of Juvenile Bullous Pemphigoid with Negative Serum BP180 ELISA Test Reveals Need for Additional Testing
DPCP Immunotherapy Yields 61.8% Hair Regrowth Rate in Pediatric Alopecia Areata